Literature DB >> 19893582

Mutant alleles associated with late-onset ornithine transcarbamylase deficiency in male patients have recurrently arisen and have been retained in some populations.

Sanae Numata1, Yoshiro Koda, Kenji Ihara, Tomo Sawada, Yoshiyuki Okano, Toshinobu Matsuura, Fumio Endo, Han-Wook Yoo, Jose A Arranz, Vicente Rubio, Bendicht Wermuth, Nicholas Ah Mew, Mendel Tuchman, Jason R Pinner, Edwin P Kirk, Makoto Yoshino.   

Abstract

We performed haplotype analysis using nine single nucleotide polymorphisms in the ornithine transcarbamylase gene to explore the ancestral origins of three mutations associated with late-onset phenotype in male patients: p.R40H, p.R277W and p.Y55D. Overall, 8 haplotypes were defined among 14 families carrying p.R40H, 5 families carrying p.R277W and 2 families with p.Y55D mutations. Of nine Japanese families carrying p.R40H, eight exhibited haplotype (HT)1, whereas the other family harbored HT2. Among three Caucasian families, one Spanish and one Australian family bore HT3; one Austrian family had HT4. Two US patients harbored HT2 and HT4. Among families carrying p.R277W, HT5 was found in one Japanese, one Korean and one US family. Two other US families had HT2 and HT6. Two families carrying p.Y55D, both Japanese, shared HT1. These results indicate that the p.R40H mutation has arisen recurrently in all populations studied, although there is evidence for a founder effect in Japan, with most cases probably sharing a common origin, and to a lesser extent in subjects of European ancestry (HT3). It is evident that p.R277W mutation has recurred in discrete populations. The p.Y55D mutation appears to have arisen from a common ancestor, because this transversion (c.163T>G) occurs rarely.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19893582     DOI: 10.1038/jhg.2009.113

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  4 in total

1.  Disease-causing mutations in the promoter and enhancer of the ornithine transcarbamylase gene.

Authors:  Yoon J Jang; Abigail L LaBella; Timothy P Feeney; Nancy Braverman; Mendel Tuchman; Hiroki Morizono; Nicholas Ah Mew; Ljubica Caldovic
Journal:  Hum Mutat       Date:  2018-01-16       Impact factor: 4.878

Review 2.  Suggested guidelines for the diagnosis and management of urea cycle disorders.

Authors:  Johannes Häberle; Nathalie Boddaert; Alberto Burlina; Anupam Chakrapani; Marjorie Dixon; Martina Huemer; Daniela Karall; Diego Martinelli; Pablo Sanjurjo Crespo; René Santer; Aude Servais; Vassili Valayannopoulos; Martin Lindner; Vicente Rubio; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

3.  Sudden unexpected fatal encephalopathy in adults with OTC gene mutations-Clues for early diagnosis and timely treatment.

Authors:  Catia Cavicchi; Maria Donati; Rossella Parini; Miriam Rigoldi; Mauro Bernardi; Francesca Orfei; Nicolò Gentiloni Silveri; Aniello Colasante; Silvia Funghini; Serena Catarzi; Elisabetta Pasquini; Giancarlo la Marca; Sean Mooney; Renzo Guerrini; Amelia Morrone
Journal:  Orphanet J Rare Dis       Date:  2014-07-16       Impact factor: 4.123

4.  Urea cycle disorders in India: clinical course, biochemical and genetic investigations, and prenatal testing.

Authors:  Sunita Bijarnia-Mahay; Johannes Häberle; Anil B Jalan; Ratna Dua Puri; Sudha Kohli; Ketki Kudalkar; Véronique Rüfenacht; Deepti Gupta; Deepshikha Maurya; Jyotsna Verma; Yosuke Shigematsu; Seiji Yamaguchi; Renu Saxena; Ishwar C Verma
Journal:  Orphanet J Rare Dis       Date:  2018-10-01       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.